Assistant Clinical Professor at Stanford University, San Francisco
Dr. Noelle Ebel is an Assistant Clinical Professor at Stanford University where she is the Director of the Alagille Syndrome Program. Her career goal is to improve the health and lives of children with liver disease, particularly for children with complex heart-liver disease, and to continue to address health disparities in pediatric liver transplantation. Her clinical and research interests lie at the intersection of the heart and the liver, specifically Fontan associated liver disease, indications for combined heart-liver transplantation and care for children with Alagille syndrome with specific attention to patients with liver disease requiring complex heart surgeries at Stanford.
Dr. Ebel was recognized by AASLD in 2016 for her work that found poorer outcomes in graft and patient survival in young adults 18-24 years old, compared to both older and younger age groups. In 2017 Dr. Ebel was the recipient of the AASLD Advanced/Transplant Hepatology Fellowship Award. In 2019 her oral presentation at the AASLD Liver Meeting described the novel finding that pediatric liver transplant recipients with technical variant grafts had decreased odds of developing hepatic artery thrombosis.
Most recently she partnered with colleagues in the Society of Pediatric Liver Transplantation (SPLIT) and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN) to create an international COVID-19 registry for pediatric patients with chronic liver disease and liver and intestinal transplant recipients.
Dr. Noelle Ebel remains committed to addressing health disparities in pediatric liver transplantation and is the Director of Policy in the Office of Child Health Equity at Stanford.